Nouveau Life Pharmaceuticals, Inc. (NOUV)
Nouveau Life Pharmaceuticals, Inc. operates in the Medical - Pharmaceuticals industry of the Healthcare sector, headquartered in Los Angeles, CA, US. The stock last traded at $0.00, up 0.00% on the session, giving a market capitalisation of $90,000. On trailing twelve-month figures it carries a trailing P/E of -38.70, a net margin of 0.0%. Its beta of -0.49 implies it has historically moved less than the broad market.
Nouveau Life Pharmaceuticals, Inc. (NOUV) is a company in its developmental stage, primarily focused on crafting nutraceutical products. It offers both natural health solutions and pharmaceutical drugs. The entity, which began operations in 1998, was previously known as Hybrid Fuels, Inc. before adopting its current designation in May 2012. Based in Ft. Lauderdale, Florida, Nouveau Life Pharmaceuticals, Inc. functions as an affiliate of EMG Marketing Solutions, Inc.
Nouveau Life Pharmaceuticals, Inc. is most often compared with the following Healthcare names: